Brief: Invivo Therapeutics Announces Completion Of Enrollment For The Inspire 2.0 Acute Spinal Cord Injury Study
02/06/2022 13:35
June 2 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT FOR
THE
INSPIRE 2.0 ACUTE SPINAL CORD INJURY STUDY
* INVIVO THERAPEUTICS HOLDINGS CORP- EXPECT TO PRESENT
TOPLINE
DATA FROM STUDY IN Q1 OF 2023
Source text for Eikon: ID:nBw8xkHr5a
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR